GAVI s mission: To save children s lives and protect people s health by increasing access to immunisation in poor countries

Transcription

1 GAVI s mission: To save children s lives and protect people s health by increasing access to immunisation in poor countries Mission Goal. Accelerate the uptake and use of underused and new vaccines Goal 2. Contribute to strengthening the capacity of integrated health systems to deliver immunisation Goal 3. Increase predictability of global and improve sustainability of national financing for immunisation Goal 4. Shape vaccine markets Cross-cutting strategic functions Advocacy, communication and public policy (ACPP) Monitoring and evaluation (M&E) SOURCE: GAVI Alliance

2 The opportunity. By 25, we can vaccinate 25 million; prevent 4 million deaths If fully funded. Driving down child mortality and morbidity with pentavalent vaccine and other vaccines Accelerating control of meningitis with MenA vaccine Helping tackle the top 2 child killers: pneumonia and diarrhoea, with pneumococcal and rotavirus vaccines Rolling out new priority vaccines (HPV, typhoid, JE, rubella *) Advancing the fight against cancer, with HPV and HepB vaccines Strengthening routine immunisation and health systems 2

3 % of contributions to GAVI count towards MUSKOKA commitments 3

4 June 3: Pledging Conference for Immunisation Co-hosted by the UK in London, following the pledging process launch in October High-level presence from several donors, recipient countries, partners and manufacturers Seeking all parties to pledge support: donors, GAVI funded countries, vaccine manufacturers, partners Multi-year pledges 2-25 For donors, a portfolio of investment vehicles, including IFFIm commitments and direct budgetary GAVI contributions Scaled up support, more than double current level of direct contributions 4

5 Countdown to June: engaging political will Donor consultations Peer to peer donor outreach Advocacy partners mobilisation Media visibility Key events and policy fora 5

6 Recent board decisions: Kigali, November/December 2 Approval of business plan Co-financing policy revision Suspension of 7 percent DPT3 filter for May 2 round Pilot performance based funding programme for low coverage countries Health Systems Funding Platform (HSFP) Close GAVI HSS window Extended platform support to all GAVI eligible countries 5-25 percent of GAVI support 6

7 Focus on strategic goals Accelerate the uptake and use of underused and new vaccines ( vaccine goal ) Contribute to strengthening the capacity of integrated health systems to deliver immunization ( health systems goal ) Increase predictability and sustaintability of financing for immunization ( financing goal) Shape vaccine markets ( market goal) 7

8 AVI set up to manage the roll out of new vaccines AMT Sub-Teams Vaccine Investment Strategy *** AMT AVI Management Team Cold Chain and Logistics Large Country Introduction AVI TAC ** AVI made up of Technical Partners, led by GAVI Secretariat AVI TAC* Program Division Supply Division Advocacy and Communication Strategic Vaccine Supply Special Studies Pneumo Intro Group*** * AVI TAC = A consortium of PATH, Johns Hopkins University (JHU), US Centers for Disease Control and Prevention (CDC) and others ** Observer Rota Intro Group*** *** Short term ad-hoc group

9 5 countries to roll out PCV by end 2 Countries Product Introduction date Nicaragua PCV3 December 2 Guyana PCV3 January 2 Kenya PCV January 2 Sierra Leone PCV3 January 2 Yemen PCV3 January 2 Mali PCV3 March 2 Congo, DR PCV3 April 4 th 2 Honduras PCV3 April 2

10 Vaccine Supply Pneumo Most countries getting PCV when wanted* Additional supply through a new call for offers April 2 Rota Specific tender issued for Sudan Mid-term procurement options being assessed *Of the 9 approved, 7 will get product when they want it, 2 is work-in-progress. We have 6M doses available from 23 under current agreements.

11 Expected Applications: May 2 Region Hib Pneumo Rota Measles 2 nd dose MenA AFRO (38) AMRO (4) 3 EMRO (8) 2 4 EURO (3) 2 SEARO (8) 3 3 WPRO (6) 4 Total (67)

12 What s the problem? Source: Kinzett,

13 What is the Platform? Ini$al partners: The World Bank A mechanism for mobilizing and making better use of new and existing funds for health more health for money Consistent with principles of greater aid effectiveness agreed in Paris and Accra and IHP+ One plan, one assessment, one fiduciary framework, one results framework Country-driven and results-focused Does not require the pooling of funds Open to all

14 Mechanisms for funding Existing funding New funding Grant/credit management

15 Current projects...stay tuned Task teams Review of cash support programmes (chair: Norway) Large countries (India and Nigeria) (chair: UNICEF) Support to partners (chair: Bill & Melinda Gates Foundation) Supply and procurement strategy revision (chair: USAID) Analytical work Review of vaccine investment grant (technical leads: WHO) Preparing for new vaccines windows (technical leads: WHO/ PATH) Video:

16 6